| Product Code: ETC6751331 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Postmenopausal Vaginal Atrophy Treatment Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 China Postmenopausal Vaginal Atrophy Treatment Market - Industry Life Cycle |
3.4 China Postmenopausal Vaginal Atrophy Treatment Market - Porter's Five Forces |
3.5 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.7 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Postmenopausal Vaginal Atrophy Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about postmenopausal vaginal atrophy (PVA) among women in China |
4.2.2 Growing aging population in China leading to a higher prevalence of postmenopausal women |
4.2.3 Technological advancements in treatment options for PVA in the Chinese market |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities and treatment options in rural areas of China |
4.3.2 Social stigma surrounding menopause and women's health issues in Chinese society |
4.3.3 High cost associated with advanced treatment options for postmenopausal vaginal atrophy in China |
5 China Postmenopausal Vaginal Atrophy Treatment Market Trends |
6 China Postmenopausal Vaginal Atrophy Treatment Market, By Types |
6.1 China Postmenopausal Vaginal Atrophy Treatment Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Therapy Type, 2021- 2031F |
6.1.3 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Estrogen based drugs, 2021- 2031F |
6.1.4 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Non-estrogen based drugs, 2021- 2031F |
6.1.5 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Postmenopausal Vaginal Atrophy Treatment Market, By Drug Form |
6.2.1 Overview and Analysis |
6.2.2 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Vaginal gel, 2021- 2031F |
6.2.3 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Creams, 2021- 2031F |
6.2.4 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Tablet, 2021- 2031F |
6.2.5 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Postmenopausal Vaginal Atrophy Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Intravaginal, 2021- 2031F |
6.3.4 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Postmenopausal Vaginal Atrophy Treatment Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 China Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 China Postmenopausal Vaginal Atrophy Treatment Market Import-Export Trade Statistics |
7.1 China Postmenopausal Vaginal Atrophy Treatment Market Export to Major Countries |
7.2 China Postmenopausal Vaginal Atrophy Treatment Market Imports from Major Countries |
8 China Postmenopausal Vaginal Atrophy Treatment Market Key Performance Indicators |
8.1 Number of women seeking treatment for postmenopausal vaginal atrophy in China |
8.2 Adoption rate of new treatment technologies for PVA in the Chinese market |
8.3 Patient satisfaction and quality of life improvement post-treatment |
9 China Postmenopausal Vaginal Atrophy Treatment Market - Opportunity Assessment |
9.1 China Postmenopausal Vaginal Atrophy Treatment Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 China Postmenopausal Vaginal Atrophy Treatment Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.3 China Postmenopausal Vaginal Atrophy Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 China Postmenopausal Vaginal Atrophy Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Postmenopausal Vaginal Atrophy Treatment Market - Competitive Landscape |
10.1 China Postmenopausal Vaginal Atrophy Treatment Market Revenue Share, By Companies, 2024 |
10.2 China Postmenopausal Vaginal Atrophy Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here